Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

News

August 31, 2011 — Results of a recent randomized controlled study show the drug-eluting stent Xience V performs well in ...

Home August 31, 2011
Home
News

August 31, 2011 — A recent study revealed more than 1,000 cardiac arrest deaths over 15 years are connected to the ...

Home August 31, 2011
Home
News

August 30, 2011 – Primary percutaneous coronary intervention (PCI) is the best reperfusion therapy for patients ...

Home August 30, 2011
Home
News

August 29, 2011 — The Guidelines on Peripheral Artery Disease (PAD) are the first document produced by the European ...

Home August 29, 2011
Home
Feature

August 25, 2011 – Transcatheter structural heart occluder maker Occlutech said this week it closed a 15 million Euro ...

Home August 25, 2011
Home
News

August 25, 2011 – The U.S. Food and Drug Administration (FDA) has released its list of pre-market approval (PMA) and 510 ...

Home August 24, 2011
Home
News

August 23, 2011 — A new study shows heart attack patients are now being treated an average of 32 minutes faster than ...

Home August 23, 2011
Home
News

August 23, 2011 — PLC Systems Inc. said the final results from the REMEDIAL II investigator-sponsored clinical trial ...

Home August 23, 2011
Home
News

August 23, 2011 — Cardium Therapeutics received the final $1.1 million payment from Royal Philips Electronics in ...

Home August 23, 2011
Home
News

August 19, 2011 - Neovasc Inc. accomplished $4.7 million in financing to complete the COSIRA clinical trial for the ...

Home August 19, 2011
Home
Feature

August 18, 2011 — The antiplatelet agent prasugrel (trade name Effient), in combination with aspirin, was associated ...

Home August 19, 2011
Home
News

August 17, 2011 — OrbusNeich announced its Genous stent showed no significant difference in target vessel failure (TVF) ...

Home August 17, 2011
Home
News

August 17, 2011 — Our Lady of Lourdes Medical Center performed its first “hybrid” heart surgery and what is believed to ...

Home August 17, 2011
Home
News

August 17, 2011 – Abbott announced today that the first patient in Japan has been treated with the Absorb bioresorbable ...

Home August 17, 2011
Home
Technology

August 12, 2011— Simbionix USA Corp., a provider of medical simulation training and education products for medical ...

Home August 12, 2011
Home
Subscribe Now